Genomic characterization of functional high-risk multiple myeloma patients

Multiple myeloma (MM) patients with suboptimal response to induction therapy or early relapse, classified as the functional high-risk (FHR) patients, have been shown to have poor outcomes. We evaluated newly-diagnosed MM patients in the CoMMpass dataset and divided them into three groups: genomic hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Soekojo, Cinnie Yentia, Chung, Tae-Hoon, Furqan, Muhammad Shaheryar, Chng, Wee Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803925/
https://www.ncbi.nlm.nih.gov/pubmed/35102139
http://dx.doi.org/10.1038/s41408-021-00576-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803925/
https://www.ncbi.nlm.nih.gov/pubmed/35102139
http://dx.doi.org/10.1038/s41408-021-00576-3

Ejemplares similares